Treasury Board of Canada Secretariat
Symbol of the Government of Canada

ARCHIVED - Patented Medicine Prices Review Board Canada


Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Table of Contents

SECTION I - OVERVIEW

Chairperson's Message

Management Representation Statement

Summary Information

Overall Departmental Performance

SECTION II - ANALYSIS OF THE PROGRAM ACTIVITY BY STRATEGIC OUTCOME

Analysis by Program Activity

Priority 1: Compliance and Enforcement

Priority 2: Report on Pharmaceutical Trends

SECTION III - SUPPLEMENTARY INFORMATION

Financial Table 1: Comparison of Planned to Actual Spending (including FTEs)

Financial Table 2: Voted and Statutory Items

Financial Table 3: Sources of Non-Respendable Revenue

Financial Table 4: Financial Statements of the Patented Medicine Prices Review Board

SECTION IV - OTHER ITEMS OF INTEREST

Organizational Information